GENMARK DIAGNOSTICS
(NASDAQ: GNMK)

GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology. The Company�s electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA), and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its eSensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.

3.800 s

-0.120 (-3.06%)
Range - - -   (-%)
Open -
Previous Close 3.920
Bid Price 3.800
Bid Volume -
Ask Price 3.810
Ask Volume -
Volume -
Value -
Remark s
Delayed prices. Updated at 03 Aug 2021 12:29.
Data powered by
View All Events

About GENMARK DIAGNOSTICS INC

GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology. The Company�s electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) cl...
more

Share your investing ideas
Please login to view stock data and analysis